Interpreting the evidence on gantenerumab for dominantly inherited Alzheimer's disease - Authors' reply.
Saved in:
| Title: | Interpreting the evidence on gantenerumab for dominantly inherited Alzheimer's disease - Authors' reply. |
|---|---|
| Authors: | Li Y; Department of Neurology, Washington University School of Medicine, St Louis, MO 63108, USA., Llibre-Guerra JJ; Department of Neurology, Washington University School of Medicine, St Louis, MO 63108, USA., Supnet C; Department of Neurology, Washington University School of Medicine, St Louis, MO 63108, USA., Atri A; Banner Sun Health Research Institute, Banner Health, Phoenix, AZ, USA., McDade EM; Department of Neurology, Washington University School of Medicine, St Louis, MO 63108, USA., Clifford DB; Department of Neurology, Washington University School of Medicine, St Louis, MO 63108, USA., Bateman RJ; Department of Neurology, Washington University School of Medicine, St Louis, MO 63108, USA. Electronic address: batemanr@wustl.edu. |
| Corporate Authors: | Dominantly Inherited Alzheimer's Disease–Trials Unit |
| Source: | The Lancet. Neurology [Lancet Neurol] 2025 Aug; Vol. 24 (8), pp. 635-636. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 101139309 Publication Model: Print Cited Medium: Internet ISSN: 1474-4465 (Electronic) Linking ISSN: 14744422 NLM ISO Abbreviation: Lancet Neurol Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
